Legal & General Gbl Health &Pharmaceutical Idx Tst (I) Inc NAV

IMA Sector:

Specialist

ISIN:

GB00B0CNH270

Fund Type:

OEIC

97.34p
   
  • PEP:
  • ISA:
  • CAT Std:
  • Date: 01-May-2024
  • Change: -0.16p
  • Change %: -0.16%
  • Currency: GBP
  • YTD change: 2.00p
  • YTD %: 2.10%

Holdings Breakdown

Holding Chart
Key % Net Assets
Johnson & Johnson 8.4%
Pfizer Inc. 5.4%
Roche Holding AG 5.1%
GlaxoSmithKline PLC 4.9%
Other 76.2%

Top 10 Holdings

Name % Net Assets
Johnson & Johnson 8.4%
Pfizer Inc. 5.4%
Roche Holding AG 5.1%
GlaxoSmithKline PLC 4.9%
Novartis 4.9%
Pfizer 3.9%
AstraZeneca PLC 3.4%
Wyeth 3.3%
Merck & Co., Inc 3.2%
Sanofi-Aventis 3.1%

Asset Allocation

No asset data available.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Info

Date 01-May-2024
NAV 97.34p
Currency GBP
Change -0.16p
% -0.16%
YTD change 2.00p
YTD % 2.10%

Fund Facts

Fund Inception 01/11/2000
Fund Manager Ali Toutounchi
TER 0.31 (31-Dec-2013)

Fund Reports

Minimum Investment
Initial n/a
Additional n/a
Savings n/a
Charges
Initial n/a
Annual Mang't 0.30%
Exit n/a

Risks

Name %
Standard deviation 0.01
Sharpe ratio -0.09

Top of Page